Targeting STAT3 to prevent colorectal cancer secondary to inflammatory bowel disease
Ended Awarded Last action
- Contract number
- 75N91021F00002
- Awardee
-
The Univeristy Of Texas M.d. Anderson Cancer Center UEI S3GMKS8ELA16 Part of University Of Texas System
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $930,247
Award facts
- Contract value 100% obligated
- $930,247.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Houston, TX 77030, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$2,701 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $932,948 |
About this award
The University of Texas MD Anderson Cancer Center received a $930,247 firm fixed-price delivery order from the National Cancer Institute to conduct preclinical research targeting STAT3 as a mechanism to prevent colorectal cancer in patients with inflammatory bowel disease. Awarded on September 16, 2021, with an ultimate completion date of September 15, 2025, this delivery order falls under the PREVENT Preclinical Drug Development Program, a comprehensive National Cancer Institute initiative designed to advance cancer prevention through systematic preclinical efficacy testing and biomarker evaluation. The work will be performed at MD Anderson's Houston, Texas facility. The contract was not designated as a small business set-aside, reflecting MD Anderson's status as a premier academic research institution with substantial competitive capabilities in federal contracting.
This delivery order is issued under the PREVENT Cancer Preclinical Drug Development Program IDC, a $149.995 billion multiple-award Indefinite Delivery/Indefinite Quantity vehicle that enables the National Cancer Institute to issue task orders for cancer preventive agent development across various contractors. MD Anderson, as a child entity of the University of Texas System, has demonstrated extensive expertise in executing complex preclinical drug development contracts for federal agencies. The specific focus on STAT3 inhibition reflects the National Cancer Institute's strategic emphasis on identifying novel molecular targets and biomarkers that can interrupt inflammatory pathways underlying cancer development, particularly in high-risk populations with inflammatory bowel disease.
Quick answers
Who was awarded contract 75N91021F00002?
75N91021F00002 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by National Cancer Institute (National Institutes of Health) on September 16, 2021.
How much is contract 75N91021F00002 worth?
The government has obligated $930,247 on 75N91021F00002.
Is contract 75N91021F00002 an order under another contract?
Yes. 75N91021F00002 is a delivery order under 75N91019D00021, an indefinite delivery contract, on PREVENT Preclinical Drug Development Program (PREVENT).
Was contract 75N91021F00002 competed?
The extent of competition for 75N91021F00002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award